Back
Celldex Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
35
CLDX
Celldex Therapeutics
Last Price:
$23.36
Seasonality Move:
-6.56%
7 Day Trial
ALL ACCESS PASS
$
7

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing slight selling pressure.
Celldex Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.96 | Buy |
20-day SMA: | 21.22 | Buy |
50-day SMA: | 20.48 | Buy |
200-day SMA: | 23.67 | Sell |
8-day EMA: | 14.26 | Buy |
20-day EMA: | 7.39 | Buy |
50-day EMA: | 3.31 | Buy |
200-day EMA: | 0.88 | Buy |
Celldex Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.01 | Buy |
Relative Strength Index (14 RSI): | 62.37 | Buy |
Chaikin Money Flow: | -171302 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.25 - 21.93) | Buy |
Bollinger Bands (100): | (18.42 - 21.66) | Buy |
Celldex Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Celldex Therapeutics Stock
Is Celldex Therapeutics Stock a Buy?
-
Celldex Therapeutics share price is 22.91 while CLDX 8-day simple moving average is 21.96, which is a Buy signal.
-
The stock price of CLDX is 22.91 while Celldex Therapeutics 20-day SMA is 21.22, which makes it a Buy.
-
Celldex Therapeutics 50-day simple moving average is 20.48 while CLDX share price is 22.91, making it a Buy technically.
-
CLDX stock price is 22.91 and Celldex Therapeutics 200-day simple moving average is 23.67, creating a Sell signal.
CLDX Technical Analysis vs Fundamental Analysis
Sell
35
Celldex Therapeutics (CLDX)
is a Sell
Is Celldex Therapeutics a Buy or a Sell?
-
Celldex Therapeutics stock is rated a SellThe current Celldex Therapeutics [CLDX] share price is $22.91. The Score for CLDX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Celldex Therapeutics Stock Info
Market Cap:
1.5B
Price in USD:
22.91
Share Volume:
803.2K
Celldex Therapeutics 52-Week Range
52-Week High:
47.00
52-Week Low:
14.40
Sell
35
Celldex Therapeutics (CLDX)
is a Sell
Celldex Therapeutics Share Price Forecast
-
What is the Celldex Therapeutics stock price today?The Celldex Therapeutics stock price is 22.91 USD today.
-
Will CLDX stock go up or go down?Celldex Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Celldex Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Celldex Therapeutics is overvalued.
Is Celldex Therapeutics Stock a Buy?
-
Celldex Therapeutics share price is 22.91 while CLDX 8-day exponential moving average is 14.26, which is a Buy signal.
-
The stock price of CLDX is 22.91 while Celldex Therapeutics 20-day EMA is 7.39, which makes it a Buy.
-
Celldex Therapeutics 50-day exponential moving average is 3.31 while CLDX share price is 22.91, making it a Buy technically.
-
CLDX stock price is 22.91 and Celldex Therapeutics 200-day simple moving average is 0.88, creating a Buy signal.
Fundamental Analysis of Celldex Therapeutics
Is Celldex Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.29 per share, a decrease this year of $1.04 per share, and a decrease next year of $0.71 per share.
Technical Analysis of Celldex Therapeutics
Should I short Celldex Therapeutics stock?
-
CLDX Moving Average Covergence Divergence (MACD) indicator is 5.01, suggesting Celldex Therapeutics is a Buy
-
Celldex Therapeutics Relative Strength Index (RSI) is 62.37, which suggest Celldex Therapeutics is overbought
-
The Bollinger Bands (25) for Celldex Therapeutics is (20.25 - 21.93), which suggest Celldex Therapeutics is a Buy
-
The Bollinger Bands (100) for Celldex Therapeutics is (18.42 - 21.66), which suggest Celldex Therapeutics is a Buy
* Celldex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.